Cargando…

Contralateral Prophylactic Mastectomy among Women with Pathogenic Variants in BRCA1/2: Overall Survival, Racial, and Ethnic Differences

BACKGROUND: Patients with unilateral breast cancer carrying pathogenic variants in BRCA1/2 have the option to undergo contralateral prophylactic mastectomy (CPM). However, differences in CPM use and survival outcomes following CPM are poorly understood in this high-risk population, in part due to a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Makhnoon, Sukh, Gutierrez Barrera, Angelica M., Bassett, Roland, Afrough, Aimaz, Bedrosian, Isabelle, Arun, Banu K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9825211/ https://www.ncbi.nlm.nih.gov/pubmed/36685664 http://dx.doi.org/10.1155/2022/1447545

Ejemplares similares

Helping Patients Understand and Cope with BRCA Mutations
por: Makhnoon, Sukh, et al.
Publicado: (2022)

Contralateral prophylactic mastectomy: current perspectives
por: Yao, Katharine, et al.
Publicado: (2016)

Predictors that Influence Election of Contralateral Prophylactic Mastectomy among Women with Ductal Carcinoma in Situ who are BRCA-Negative
por: Elsayegh, Nisreen, et al.
Publicado: (2015)

Trends in utilization of contralateral prophylactic mastectomy among different age, racial and ethnic groups
por: Owusu-Brackett, Nicci, et al.
Publicado: (2023)

Contralateral prophylactic mastectomy rate and predictive factors among patients with breast cancer who underwent multigene panel testing for hereditary cancer
por: Elsayegh, Nisreen, et al.
Publicado: (2018)

Clinical outcome for BRCA1 and BRCA2 mutation carriers after contralateral prophylactic mastectomy
por: Schmidt, MK, et al.
Publicado: (2005)

Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers
por: van Sprundel, T C, et al.
Publicado: (2005)

Abstract: Contralateral Prophylactic Mastectomy: The Argument for Bilateral Mastectomies and Reconstruction
por: Schultz, Benjamin D., et al.
Publicado: (2018)

Influencers of the Decision to Undergo Contralateral Prophylactic Mastectomy among Women with Unilateral Breast Cancer
por: Singareeka Raghavendra, Akshara, et al.
Publicado: (2021)

Second primary breast cancer after unilateral mastectomy alone or with contralateral prophylactic mastectomy
por: Agarwal, Shailesh, et al.
Publicado: (2020)

Better contralateral breast cancer risk estimation and alternative options to contralateral prophylactic mastectomy
por: Davies, Kalatu R, et al.
Publicado: (2015)

Outcomes of contralateral prophylactic mastectomy in relation to familial history: a decision analysis (BRCR-D-16-00033)
por: Davies, Kalatu R., et al.
Publicado: (2016)

Motivations for contralateral prophylactic mastectomy as a function of socioeconomic status
por: Baptiste, Dadrie F., et al.
Publicado: (2017)

Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability
por: Scheepens, Josien C.C., et al.
Publicado: (2021)

Contralateral risk reducing mastectomy in Non-BRCA-Mutated patients
por: Falco, Giuseppe, et al.
Publicado: (2016)

Trends in contralateral prophylactic mastectomy rate according to clinicopathologic and socioeconomic status
por: Jeon, Ho Jong, et al.
Publicado: (2019)

Practices and Views of US Oncologists and Genetic Counselors Regarding Patient Recontact After Variant Reclassification: Results of a Nationwide Survey
por: Makhnoon, Sukh, et al.
Publicado: (2023)

Social Network, Surgeon, and Media Influence on the Decision to Undergo Contralateral Prophylactic Mastectomy
por: Venetis, Maria K., et al.
Publicado: (2018)

Contralateral prophylactic mastectomy in male breast cancer: where do we stand?
por: Sciarra, Antonella, et al.
Publicado: (2021)

Effect of rurality and travel distance on contralateral prophylactic mastectomy for unilateral breast cancer
por: Wahlen, Madison M., et al.
Publicado: (2023)

Immediate Implant-Based Reconstruction of the Contralateral or Bilateral Prophylactic Mastectomies: Risk Factor Analysis for Index and Prophylactic Breast
por: Dolen, Utku Can, et al.
Publicado: (2020)

Disparities in contralateral prophylactic mastectomy use among women with early-stage breast cancer
por: Kim, Younji, et al.
Publicado: (2017)

Patient opinions on contralateral prophylactic mastectomy: A patient-driven discussion in need of tuning?
por: Brown, Zachary M., et al.
Publicado: (2022)

Preserving choice in breast cancer treatment: A different perspective on contralateral prophylactic mastectomy
por: Pender, Kelly, et al.
Publicado: (2023)

Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis
por: Metcalfe, Kelly, et al.
Publicado: (2014)

The Angelina Jolie Effect in Jewish Law: Prophylactic Mastectomy and Oophorectomy in BRCA Carriers
por: Grossman, Sharon Galper
Publicado: (2015)

Abstract 71: Postoperative Quality of Life in Patients Undergoing Contralateral Prophylactic Mastectomy with Breast Reconstruction
por: Rizzo, Amanda M., et al.
Publicado: (2018)

Clinical features, prognosis, and influencing factors of contralateral prophylactic mastectomy in 58 patients with breast cancer
por: Zheng, Yiqiong, et al.
Publicado: (2020)

Nationwide Trends in Contralateral Prophylactic Mastectomies: An Analysis of 55,060 Unilateral Breast Cancer Patients
por: Shaheen, Mohammed S., et al.
Publicado: (2022)

Effectiveness of Prophylactic Mastectomy
por: Berkeš, Andrej, et al.
Publicado: (2023)

The Importance of Risk-Reducing Prophylactic Mastectomy in Breast Cancer (BRCA) Carriers: A Case Report
por: Ochaney, Priyanka, et al.
Publicado: (2019)

Plastic and Reconstructive Surgeons' Knowledge and Comfort of Contralateral Prophylactic Mastectomy: A Survey of the American Society of Plastic Surgeons
por: Lopez, Christopher D., et al.
Publicado: (2019)

Abstract 9. Morbidity and Quality of Life Outcomes of Breast Reconstruction for Unilateral Mastectomy vs. Additional Contralateral Prophylactic Mastectomy: a Cohort Study of 211 Breast Reconstruction Patients Morbidity and Quality of Life Outcomes of Breast Reconstruction for Unilateral Mastectomy vs. Additional Contralateral Prophylactic Mastectomy: a Cohort Study of 211 Breast Reconstruction Patients
por: Sebai, Mohamad E., et al.
Publicado: (2017)

Factors associated with contralateral preventive mastectomy
por: Yakoub, Danny, et al.
Publicado: (2015)

Perceptions of Prophylactic Mastectomy in Korea
por: Yoon, Han Young, et al.
Publicado: (2016)

Contralateral Prophylactic Mastectomy (CPM) Consensus Statement from the American Society of Breast Surgeons: Data on CPM Outcomes and Risks
por: Boughey, Judy C., et al.
Publicado: (2016)

The PARP inhibitor AZD2281 (Olaparib) induces autophagy/mitophagy in BRCA1 and BRCA2 mutant breast cancer cells
por: Arun, Banu, et al.
Publicado: (2015)

The Manchester guidelines for contralateral risk-reducing mastectomy
por: Basu, Narendra Nath, et al.
Publicado: (2015)

Abstract 183: Contralateral Prophylactic Mastectomy And Breast Reconstruction Trends: A 10-year Review At A Tertiary Care Center
por: Patel, Harsh, et al.
Publicado: (2020)

Abstract 4: Morbidity and Quality of Life Outcomes of Breast Reconstruction for Unilateral Mastectomy vs. Additional Contralateral Prophylactic Mastectomy: a Cohort Study of 211 Breast Reconstruction Patients
por: Sebai, Mohamad E., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_21244mgvvamijchsgsq2sv8nvm